Lignin-derived lignophenols attenuate oxidative and inflammatory damage to the kidney in streptozotocin-induced diabetic rats

References

• Baynes JW, . Role of oxidative stress in development of complications in diabetes. Diabetes. 1991; 40:405–412.
   PubMed Web of Science ®Google Scholar
• Jerums G, Panagiotopoulos S, Forbes J, Osicka T, Cooper M, . Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease. Arch Biochem Biophys. 2003; 419:55–62.
   PubMed Web of Science ®Google Scholar
• Figueroa-Romero C, Sadidi M, Feldman EL, . Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord. 2008; 9:301–314.
   PubMed Web of Science ®Google Scholar
• Thallas-Bonke V, Thorpe SR, Coughlan MT, Fukami K, Yap FY, Sourris KC, Penfold SA, Bach LA, Cooper ME, Forbes JM, . Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway. Diabetes. 2008; 57:460–469.
   PubMed Web of Science ®Google Scholar
• Gao L, Mann GE, . Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signaling. Cardiovasc Res. 2009; 82:9–20.
   PubMed Web of Science ®Google Scholar
• Young BA, Johnson RJ, Alpers CE, Eng E, Gordon K, Floege J, Couser WG, Seidel K, . Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int. 1995; 47:935–944.
   PubMed Web of Science ®Google Scholar
• Chow FY, Nikolic-Paterson DJ, Atkins RC, Tesch GH, . Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis. Nephrol Dial Transplant. 2004; 19:2987–2996.
   PubMed Web of Science ®Google Scholar
• Tesch GH, . MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am J Physiol Renal Physiol. 2008; 294:F697–F701.
   PubMed Web of Science ®Google Scholar
• Koya D, Lee IK, Ishii H, Kanoh H, King GL, . Prevention of glomerular dysfunction in diabetic rats by treatment with d-α-tocopherol. J Am Soc Nephrol. 1997; 8:426–435.
   PubMed Web of Science ®Google Scholar
• Melhem MF, Craven PA, Liachenko J, DeRubertis FR, . α-lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes. J Am Soc Nephrol. 2002; 13:108–116.
   PubMed Web of Science ®Google Scholar
• Anjaneyulu M, Chopra K, . Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol. 2004; 31:244–248.
   PubMed Web of Science ®Google Scholar
• Sato S, Yamate J, Hori Y, Hatai A, Nozawa M, Sagai M, . Protective effect of polyphenol-containing azuki bean (Vigna angularis) seed coats on the renal cortex in streptozotocin-induced diabetic rats. J Nutr Biochem. 2005; 16:547–553.
   PubMed Web of Science ®Google Scholar
• Funaoka M, Fukatsu S, . Characteristics of lignin structural conversion in a phase-separative reaction system composed of cresol and sulfuric acid. Holzforschung. 1996; 50:245–252.
   Google Scholar
• Fujita S, Ohmae E, Funaoka M, . In vitro the antioxidant activity of lignophenol from Beech (Fagus crenata Blume) and Hinoki (Cryptomeria japonica D. Don). J Jpn Assoc Dietary Fiber Res. 2003; 7:13–19.
   Google Scholar
• Akao Y, Seki N, Nakagawa Y, Yi H, Matsumoto K, Ito Y, Ito K, Funaoka M, Maruyama W, Naoi M, Nozawa Y, . A highly bioactive lignophenol derivative from bamboo lignin exhibits a potent activity to suppress apoptosis induced by oxidative stress in human neuroblastoma SH-SY5Y cells. Bioorg Med Chem. 2004; 12:4791–4801.
   PubMed Web of Science ®Google Scholar
• Sato S, Fujita S, Funaoka M, Komori M, Kurasaki M, . Protective effect of lignophenol derivative from beech (Fagus crenata Blume) on copper- and zinc-mediated cell death in PC12 cells. Basic Clin Pharmacol Toxicol. 2006; 99:353–357.
   Google Scholar
• O'Hara Y, Peterson TE, Harrison DG, . Hypercholesterolaemia increases endothelial superoxide anion production. J Clin Invest. 1993; 91:2546–2551.
   PubMedGoogle Scholar
• Kerr S, Brosnan JM, McIntyre M, Reid JL, Dominiczak AF, Hamilton CA, . Superoxide anion production is increased in a model of genetic hypertension. Hypertension. 1999; 33:1353–1358.
   PubMed Web of Science ®Google Scholar
• López-De León A, Rojkind M, . A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem. 1985; 33:737–743.
   PubMed Web of Science ®Google Scholar
• Dijkstra CD, Dopp EA, Joling P, Kraal G, . The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology. 1985; 54:589–599.
   PubMed Web of Science ®Google Scholar
• Kakimoto M, Inoguchi T, Sonta T, Yu HY, Imamura M, Etoh T, Hashimoto T, Nawata H, . Accumulation of 8-hydroxy-2′-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats. Diabetes. 2002; 51:1588–1595.
   PubMed Web of Science ®Google Scholar
• Hayaishi-Okano R, Yamasaki Y, Kajimoto Y, Sakamoto K, Ohtoshi K, Katakami N, Kawamori D, Miyatsuka T, Hatazaki M, Hazama Y, Hori M, . Association of NAD(P)H oxidase p22 phox gene variation with advanced carotid atherosclerosis in Japanese type 2 diabetes. Diabetes Care. 2003; 26:458–463.
   PubMed Web of Science ®Google Scholar
• Li JM, Shah AM, . ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. J Am Soc Nephrol. 2003; 14:S221–S226.
   PubMed Web of Science ®Google Scholar
• Forbes JM, Coughlan MT, Cooper ME, . Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes. 2008; 57:1446–1454.
   PubMed Web of Science ®Google Scholar
• Wolf G, Ziyadeh FN, . Molecular mechanisms of diabetic renal hypertrophy. Kidney Int. 1999; 56:393–405.
   PubMed Web of Science ®Google Scholar
• Li JH, Huang XR, Zhu HJ, Johnson R, Lan HY, . Role of TGF-β signaling in extracellular matrix production under high glucose conditions. Kidney Int. 2003; 63:2010–2019.
   PubMed Web of Science ®Google Scholar
• Sassy-Prigent C, Heudes D, Mandet C, Belair MF, Michel O, Perdereau B, Bariety J, Bruneval P, . Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes. 2000; 49:455–475.
   Google Scholar
• Nguyen D, Ping F, Mu W, Hill P, Atkins RC, Chadban SJ, . Macrophage accumulation in human progressive diabetic nephropathy. Nephrology. 2006; 11:226–231.
   PubMed Web of Science ®Google Scholar
• Shi XY, Hou FF, Niu HX, Wang GB, Xie D, Guo ZJ, Zhou ZM, Yang F, Tian JW, Zhang X, . Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase. Endocrinology. 2008; 149:1829–1839.
   PubMed Web of Science ®Google Scholar
• Reeves WB, Andreoli TE, . Transforming growth factor-β contributes to progressive diabetic nephropathy. Proc Nati Acad Sci USA. 2000; 97:7667–7669.
   PubMed Web of Science ®Google Scholar
• Chow FY, Nikolic-Paterson DJ, Ozols E, Atkins RC, Rollin BJ, Tesch GH, . Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int. 2006; 69:73–80.
   PubMed Web of Science ®Google Scholar
• Ha H, Yu MR, Choi YJ, Kitamura M, Lee HB, . Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells. J Am Soc Nephrol. 2002; 13:894–902.
   PubMed Web of Science ®Google Scholar
• Amann B, Tinzmann R, Angelkort B, . ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1. Diabetes Care. 2003; 26:2421–2425.
   PubMed Web of Science ®Google Scholar
• Galkina E, Ley K, . Leukocyte recruitment and vascular injury in diabetic nephropathy. J Am Soc Nephrol. 2006; 17:368–377.
   PubMed Web of Science ®Google Scholar
• San Martín A, Du P, Dikalova A, Lassègue B, Aleman M, Góngora MC, Brown K, Joseph G, Harrison DG, Taylor WR, Jo H, Griendling KK, . Reactive oxygen species-selective regulation of aortic inflammatory gene expression in Type 2 diabetes. Am J Physiol Heart Circ Physiol. 2007; 292:H2073–H2082.
   PubMed Web of Science ®Google Scholar
• Satoh M, Fujimoto S, Haruna Y, Arakawa S, Horike H, Komai N, Sasaki T, Tsujioka K, Makino H, Kashihara N, . NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am J Physiol Renal Physiol. 2005; 288:F1144–F1152.
   PubMed Web of Science ®Google Scholar
• Gorin Y, Block K, Hernandez J, Bhandari B, Wagner B, Barnes JL, Abboud HE, . Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem. 2005; 280:39616–39626.
   PubMed Web of Science ®Google Scholar
• Wendt MC, Daiber A, Kleschyov AL, Mülsch A, Sydow K, Schulz E, Chen K, Keaney JFJr, Lassègue B, Walter U, Griendling KK, Münzel T, . Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4. Free Radic Biol Med. 2005; 39:381–391.
   PubMed Web of Science ®Google Scholar
• Asaba K, Tojo A, Onozato ML, Goto A, Quinn MT, Fujita T, Wilcox CS, . Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int. 2005; 67:1890–1898.
   PubMed Web of Science ®Google Scholar